Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia

Chronobiology International

Volumn 31, Issue 7, 2014, Pages 838-844

  Jung, Jin Sook ^a   Lee, Heon Jeong ^a,b   Cho, Chul Hyun ^a,b   Kang, Seung Gul ^c   Yoon, Ho Kyoung ^a,b   Park, Young Min ^d   Moon, Joung Ho ^a,b   Yang, Hee Jung ^a,b   Song, Hyun Mi ^a,b   Kim, Leen ^a,b  

^a Korea University College of Medicine   (South Korea)

^b College of Medicine   (South Korea)

^c Gachon University   (South Korea)

^d Inje University   (South Korea)

Author keywords

Antipsychotics; Circadian rhythm; CLOCK gene; Restless legs syndrome

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CLOCK PROTEIN, HUMAN; NERVE PROTEIN; NPAS2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR CLOCK;

ADULT; AGED; CIRCADIAN RHYTHM; COMPLICATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; SCHIZOPHRENIA; YOUNG ADULT;

ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CIRCADIAN RHYTHM; CLOCK PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; RESTLESS LEGS SYNDROME; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84903723903     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2014.914034     Document Type: Article

References (61)

1. Ali NJ, Davies RJ, Fleetham JA, et al. (1991). Periodic movements of the legs during sleep associated with rises in systemic blood pressure. Sleep. 14:163-5.
2. Baier PC, Trenkwalder C. (2007). Circadian variation in restless legs syndrome. Sleep Med. 8:645-50. (Pubitemid 47181204)
3. Barnes TR. (1989). A rating scale for drug-induced akathisia. Br J Psychiatry. 154:672-6. (Pubitemid 19154942)
4. Bonati MT, Ferini-Strambi L, Aridon P, et al. (2003). Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain. 126:1485-92. (Pubitemid 36644391)
5. Borjigin J, Zhang LS, Calinescu AA. (2012). Circadian regulation of pineal gland rhythmicity. Mol Cell Endocrinol. 349:13-19.
6. Cervenka S, Pålhagen SE, Comley RA, et al. (2006). Support for dopaminergic hypoactivity in restless legs syndrome: A PET study on D2-receptor binding. Brain. 129:2017-28. (Pubitemid 44289067)
7. Champion D, Pathirana S, Flynn C, et al. (2012). Growing pains: Twin family study evidence for genetic susceptibility and a genetic relationship with restless legs syndrome. Eur J Pain. 16:1224-31.
8. Chen S, Ondo WG, Rao S, et al. (2004). Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet. 74:876-85. (Pubitemid 38568962)
9. Cho CH, Kang SG, Choi JE, et al. (2009a). Association between antipsychotics-induced restless legs syndrome and tyrosine hydroxylase gene polymorphism. Psychiatry Investig. 6:211-15.
10. Cho SJ, Hong JP, Hahm BJ, et al. (2009b). Restless legs syndrome in a community sample of Korean adults: Prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep. 32:1069-76.
11. Desautels A, Turecki G, Montplaisir J, et al. (2001). Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet. 69:1266-70. (Pubitemid 33124208)
12. Desautels A, Turecki G, Montplaisir J, et al. (2002). Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology. 59:215-19. (Pubitemid 34779180)
13. Dowling P, Klinker F, Stadelmann C, et al. (2011). Dopamine D3 receptor specifically modulates motor and sensory symptoms in iron-deficient mice. J Neurosci. 31:70-7.
14. Earley CJ, Hyland K, Allen RP. (2006). Circadian changes in CSF dopaminergic measures in restless legs syndrome. Sleep Med. 7:263-8.
15. Edwards RR, Quartana PJ, Allen RP, et al. (2011). Alterations in pain responses in treated and untreated patients with restless legs syndrome: Associations with sleep disruption. Sleep Med. 12:603-9.
16. Faul F, Erdfelder E, Buchner A, Lang AG. (2009). Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods. 41:1149-60.
17. Fehnel S, Zografos L, Curtice T, et al. (2008). The burden of restless legs syndrome: An assessment of work productivity, sleep, psychological distress, and health status among diagnosed and undiagnosed individuals in an internet-based panel. Patient. 1: 201-10.
18. Ferini-Strambi L. (2007). RLS-like symptoms: Differential diagnosis by history and clinical assessment. Sleep Med. 8:S3-6. (Pubitemid 47040664)
19. Gold R, Lenox RH. (1995). Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence. J Clin Psychiatry. 56:476-83.
20. Gündüz A, Adatepe NU, Kiziltan ME, et al. (2012). Circadian changes in cortical excitability in restless legs syndrome. J Neurol Sci. 316:122-5.
21. Hampp G, Ripperger JA, Houben T, et al. (2008). Regulation of monoamine oxidase A by circadian-CLOCK components implies CLOCK influence on mood. Curr Biol. 18:678-83.
22. Han OS, Hong JP. (2000). Structured clinical interview for DSM-IV Axis I Disorder - Korean version. Seoul: Hana Medical Publishing.
23. Haque R, Ali FG, Biscoglia R, et al. (2010). CLOCK and NPAS2 have overlapping roles in the circadian oscillation of arylalkylamine N-acetyltransferase mRNA in chicken cone photoreceptors. J Neurochem. 113:1296-306.
24. Hening WA, Walters AS, Wagner M, et al. (1999). Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep. 22:901-12. (Pubitemid 29526510)
25. Kafka MS, Wirz-Justice A, Naber D, et al. (1983). Circadian rhythms in rat brain neurotransmitter receptors. Fed Proc. 42:2796-801. (Pubitemid 13039370)
26. Kang SG, Lee HJ, Choi JE, et al. (2007a). Possible association between G-protein β3 subunit C825T polymorphism and antipsychotic-induced restless legs syndrome in schizophrenia. Acta Neuropsychiatr. 19:351-6.
27. Kang SG, Lee HJ, Jung SW, et al. (2007b). Characteristics and clinical correlates of restless legs syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 31:1078-83. (Pubitemid 46810100)
28. Kang SG, Lee HJ, Park YM, et al. (2013). The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia. Hum Psychopharmacol. 28:117-23.
29. Kang SG, Park YM, Choi JE, et al. (2010). Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia. Hum Psychopharmacol 25:397-403.
30. Kang SG, Lee HJ, Choi JE, et al. (2008). Association study between antipsychotics-induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia. Neuropsychobiology. 57:49-54.
31. Karroum E, Konofal E, Arnulf I. (2008). Restless-legs syndrome. Rev Neurol (Paris). 164:701-21.
32. Kemlink D, Plazzi G, Vetrugno R, et al. (2008). Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics. 9:75-82.
33. Kim WH, Kim BS, Kim SK, et al. (2012). Restless legs syndrome in older people: A community-based study on its prevalence and association with major depressive disorder in older Korean adults. Int J Geriatr Psychiatry. 27:565-72.
34. Kripke DF, Shadan FF, Dawson A, et al. (2010). Genotyping sleep disorders patients. Psychiatry Investig. 7:36-42.
35. Levchenko A, Montplaisir JY, Asselin G, et al. (2009). Autosomal-dominant locus for Restless Legs Syndrome in French-Canadians on chromosome 16p12.1. Mov Disord. 24: 40-50.
36. Levchenko A, Provost S, Montplaisir JY, et al. (2006). A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. Neurology. 67:900-1. (Pubitemid 44394216)
37. Lykke J, Hesse M, Austin SF, Oestrich I. (2008). Validity of the BPRS, the BDI and the BAI in dual diagnosis patients. Addict Behav. 33:292-300. (Pubitemid 350253175)
38. Michaud M, Dumont M, Selmaoui B, et al. (2004). Circadian rhythm of restless legs syndrome: Relationship with biological markers. Ann Neurol. 55:372-80. (Pubitemid 38269589)
39. Miyamoto M, Miyamoto T, Iwanami M, et al. (2009). Pathophysiology of restless legs syndrome. Brain Nerve. 61: 523-32.
40. Montplaisir J, Boucher S, Poirier G, et al. (1997). Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria. Mov Disord. 12:61-5. (Pubitemid 27032881)
41. Odrcich M, Bailey JM, Cahill CM, Gilron I. (2006). Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: Diurnal pain variation and effects of analgesic therapy. Pain. 120:207-12. (Pubitemid 43077184)
42. Park YM, Lee HJ, Kang SG, et al. (2010). Prevalence of idiopathic and secondary restless legs syndrome in Korean Women. Gen Hosp Psychiatry. 32:164-8.
43. Pichler I, Marroni F, Volpato CB, et al. (2006). Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate. Am J Hum Genet. 79:716-23. (Pubitemid 44452749)
44. Poceta JS, Parsons L, Engelland S, Kripke DF. (2009). Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease. Sleep Med. 10: 129-33.
45. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911-29.
46. Rasmussen J, Videbech P. (2011). Restless legs syndrome and depression. Ugeskr Laeger. 173:2113-17.
47. Schormair B, Kemlink D, Roeske D, et al. (2008). PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nature Genet. 40:946-8.
48. Soldatos CR, Dikeos DG, Paparrigopoulos TJ. (2003). The diagnostic validity of the Athens Insomnia Scale. J Psychosom Res. 55: 263-7. (Pubitemid 38366230)
49. Stefansson H, Rye DB, Hicks A, et al. (2007). A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 357: 639-47. (Pubitemid 47267233)
50. Torner C, Aguilar-Roblero R. (2001). Asynchrony in the diurnal rhythms of dopaminergic D2 receptors in different brain regions of the rat. Biol Rhythm Res. 32:363-88.
51. Torner C, Herrera-Estrella M, Gutiérrez JA, et al. (2003). Diurnal variations of extrapyramidal symptoms induced by haloperidol in schizophrenic subjects. Int J Neuropsychopharmacol. 6: 243-6. (Pubitemid 37248002)
52. Torner C, Sánchez-Hurtado L, Aguilar-Roblero R. (1998). Diurnal variations of striatal D2 dopaminergic receptors and its relation with haloperidol-induced catalepsy. Biol Rhythm Res. 29: 538-45. (Pubitemid 29166566)
53. Trenkwalder C, Hening WA, Walters AS, et al. (1999). Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord. 14:102-10. (Pubitemid 29224683)
54. Trotti LM, Rye DB. (2011). Restless legs syndrome. Handb Clin Neurol. 100:661-73.
55. Walters AS, LeBrocq C, Dhar A, et al. (2003). Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 4:121-32. (Pubitemid 36527232)
56. Whittom S, Dumont M, Petit D, et al. (2010). Effects of melatonin and bright light administration on motor and sensory symptoms of RLS. Sleep Med. 11:351-5.
57. Winkelmann J, Schormair B, Lichtner P, et al. (2007). Genomewide association study of restless legs syndrome identifies common variants in three genomic regions. Nature Genet. 39: 1000-6. (Pubitemid 47185185)
58. Winkelmann J, Wetter TC, Collado-Seidel V, et al. (2000). Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 23:597-602. (Pubitemid 30636654)
59. Winter AC, Schürks M, Glynn RJ, et al. (2012). Restless legs syndrome and risk of incident cardiovascular disease in women and men: Prospective cohort study. BMJ Open. 2:e000866.
60. Wirz-Justice A. (1986). Circadian rhythms of receptors. Chronobiol Int. 3:87-146.
61. Zisapel N. (2001). Melatonin-dopamine interactions: From basic neurochemistry to a clinical setting. Cell Mol Neurobiol. 21: 605-16. (Pubitemid 34538858)